Murata Yasuhiro 村田泰洋

Researcher Number	20572655
Other IDs
Affiliation (Current)	2025: 三重大学, 医学部附属病院, 講師
Affiliation (based on the past Project Information) *help	2018 – 2023: 三重大学, 医学部附属病院, 講師 2016 – 2017: 三重大学, 医学系研究科, 助教 2015: 三重大学, 医学(系)研究科(研究院), 助教
Review Section/Research Field	Principal Investigator Digestive surgery Except Principal Investigator Basic Section 55020:Digestive surgery-related / Gastroenterology
Keywords	Principal Investigator 集学的治療 / 局所進行膵癌 / 局所進行切除不能膵癌 / 癌微小環境 / Tenascin-C / 細胞外マトリックス / 組織学的効果 / 化学放射線治療 / 浸潤性膵管癌 Except Principal Investigator 化学放射線治療 … More / microRNA / 膵癌 / 新規臨床病期システム / 局所進行膵癌 / 境界切除可能膵癌 / 局所進行切除不能膵癌 / 免疫栄養指標 / 生物学的悪性度 / 浸潤性膵管癌 Less

tailor-made medicine using microRNA for pancreatic cancer
- Principal Investigator
  
  水野修吾
- Project Period (FY)
  2021 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Mie University
Establishment and therapeutic application of a new clinical staging system based on the biological features of pancreatic adenocarcinoma
- Principal Investigator
  
  Isaji Shuji
- Project Period (FY)
  2017 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Mie University
Exploring the effect of chemoradiotherapy on caner microenvironment and its clinical application in patients with pancreatic adenocarcinomaPrincipal Investigator
- Principal Investigator
  
  Murata Yasuhiro
- Project Period (FY)
  2015 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Digestive surgery
- Research Institution
  Mie University

All 2023 2022 2020 2019 2018 2017 2016 2015

All Journal Article Presentation

[Journal Article] Anterior versus posterior radical antegrade modular pancreatosplenectomy for pancreatic body and tail cancer: an inverse probability of treatment weighting with survival analysis.2023
- Author(s)
  Kuriyama N, Maeda K, Shinkai T, Ito T, Gyoten K, Hayasaki A, Fujii T, Iizawa Y, Murata Y, Tanemura A, Kishiwada M, Nagata M, Ichikawa S, Mizuno S.
- Journal Title
  
  Surg Today.
  
  Volume: 53 Issue: 8 Pages: 917-929
- DOI
  10.1007/s00595-023-02651-7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K08706, KAKENHI-PROJECT-22K09138
[Journal Article] Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic ductal adenocarcinoma treated with chemoradiotherapy - comparison of T category between the American Joint Committee on Cancer and Japan Pancreas Society.2023
- Author(s)
  Hayasaki A, Mizuno S, Nagata M, Kaluba B, Maeda K, Shinkai T, Ito T, Gyoten K, Fujii T, Iizawa Y, Tanemura A, Murata Y, Kuriyama N, Isaji S, Kishiwada M.
- Journal Title
  
  HPB (Oxford)
  
  Volume: 25 Issue: 10 Pages: 1268-1277
- DOI
  10.1016/j.hpb.2023.06.015
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K08706, KAKENHI-PROJECT-22K09138
[Journal Article] Predictive risk factors for early recurrence in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection after preoperative chemoradiotherapy2022
- Author(s)
  Murata Yasuhiro、Ogura Toru、Hayasaki Aoi、Gyoten Kazuyuki、Ito Takahiro、Iizawa Yusuke、Fujii Takehiro、Tanemura Akihiro、Kuriyama Naohisa、Kishiwada Masashi、Sakurai Hiroyuki、Mizuno Shugo
- Journal Title
  
  PLOS ONE
  
  Volume: 17 Issue: 4 Pages: e0264573-e0264573
- DOI
  10.1371/journal.pone.0264573
- Data Source
  KAKENHI-PROJECT-21K08706
[Journal Article] Role of Serum Carcinoma Embryonic Antigen (CEA) Level in Localized Pancreatic Adenocarcinoma2020
- Author(s)
  Kato Hiroyuki、Kishiwada Masashi、Hayasaki Aoi、Chipaila Jackson、Maeda Koki、Noguchi Daisuke、Gyoten Kazuyuki、Fujii Takehiro、Iizawa Yusuke、Tanemura Akihiro、Murata Yasuhiro、Kuriyama Naohisa、Usui Masanobu、Sakurai Hiroyuki、Isaji Shuji、Mizuno Shugo
- Journal Title
  
  Annals of Surgery
  
  Volume: - Issue: 5 Pages: e698-e707
- DOI
  10.1097/sla.0000000000004148
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Prognostic Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients2019
- Author(s)
  Ichikawa Ken、Mizuno Shugo、Hayasaki Aoi、Kishiwada Masashi、Fujii Takehiro、Iizawa Yusuke、Kato Hiroyuki、Tanemura Akihiro、Murata Yasuhiro、Azumi Yoshinori、Kuriyama Naohisa、Usui Masanobu、Sakurai Hiroyuki、Isaji Shuji
- Journal Title
  
  Cancers
  
  Volume: 11(4) Issue: 4 Pages: 514-514
- DOI
  10.3390/cancers11040514
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy2019
- Author(s)
  Jaseanchiun Warakorn、Kato Hiroyuki、Hayasaki Aoi、Fujii Takehiro、Iizawa Yusuke、Tanemura Akihiro、Murata Yasuhiro、Azumi Yoshinori、Kuriyama Naohisa、Kishiwada Masashi、Mizuno Shugo、Usui Masanobu、Sakurai Hiroyuki、Isaji Shuji
- Journal Title
  
  Pancreatology
  
  Volume: 19(2) Issue: 2 Pages: 307-315
- DOI
  10.1016/j.pan.2019.01.020
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes2019
- Author(s)
  Hayasaki Aoi、Murata Yasuhiro、Usui Masanobu、Hibi Taemi、Fujii Takehiro、Iizawa Yusuke、Kato Hiroyuki、Tanemura Akihiro、Azumi Yoshinori、Kuriyama Naohisa、Kishiwada Masashi、Mizuno Shugo、Sakurai Hiroyuki、Uchida Katsunori、Isaji Shuji
- Journal Title
  
  BioMed Research International
  
  Volume: 2019 Pages: 1-12
- DOI
  10.1155/2019/5738614
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor2019
- Author(s)
  Takeuchi Taijiro、Mizuno Shugo、Murata Yasuhiro、Hayasaki Aoi、Kishiwada Masashi、Fujii Takehiro、Iizawa Yusuke、Kato Hiroyuki、Tanemura Akihiro、Kuriyama Naohisa、Azumi Yoshinori、Usui Masanobu、Sakurai Hiroyuki、Isaji Shuji
- Journal Title
  
  Pancreas
  
  Volume: 48(2) Issue: 2 Pages: 281-291
- DOI
  10.1097/mpa.0000000000001227
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes2019
- Author(s)
  Hayasaki, Aoi & Murata, Yasuhiro & Usui, Masanobu & Hibi, Taemi & Fujii, Takehiro & Iizawa, Yusuke & Kato, Hiroyuki & Tanemura, Akihiro & Azumi, Yoshinori & Kuriyama, Naohisa & Kishiwada, Masashi & Mizuno, Shugo & Sakurai, Hiroyuki & Uchida, Katsunori & Isaji, Shuji.
- Journal Title
  
  BioMed Research International.
  
  Volume: 2019 Pages: 1-12
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K19881
[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor.2019
- Author(s)
  Takeuchi T, Mizuno S, Murata Y, Hayasaki A, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Kuriyama N, Azumi Y, Usui M, Sakurai H, Isaji S.
- Journal Title
  
  Pancreas.
  
  Volume: 48(2) Pages: 281-291
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy.2019
- Author(s)
  Jaseanchiun W, Kato H, Hayasaki A, Fujii T, Iizawa Y, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Usui M, Sakurai H, Isaji S.
- Journal Title
  
  Pancreatology.
  
  Volume: 19(2) Pages: 307-315
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor.2019
- Author(s)
  Takeuchi T, Mizuno S, Murata Y, Hayasaki A, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Kuriyama N, Azumi Y, Usui M, Sakurai H, Isaji S.
- Journal Title
  
  Pancreas.
  
  Volume: 48(2) Pages: 281-291
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K19881
[Journal Article] Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients.2019
- Author(s)
  Ichikawa K, Mizuno S, Hayasaki A, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Usui M, Sakurai H, Isaji S
- Journal Title
  
  Cancers (Basel).
  
  Volume: 11(4).
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Clinical Significance of Histological Effect and Intratumor Stromal Expression of Tenascin-C in Resected Specimens After Chemoradiotherapy for Initially Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma2018
- Author(s)
  Hayasaki A, Murata Y, Usui M, Hibi T, Ito T, Iizawa Y, Kato H, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Yoshida T, Isaji S.
- Journal Title
  
  Pancreas
  
  Volume: 47(4) Pages: 390-399
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K19881
[Journal Article] Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer.2018
- Author(s)
  Hayasaki A, Isaji S, Kishiwada M, Fujii T, Iizawa Y, Kato H, Tanemura A, Murata Y, Azumi Y, Kuriyama N, Mizuno S, Usui M, Sakurai H.
- Journal Title
  
  Cancers (Basel).
  
  Volume: 10(3)
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09459
[Journal Article] Clinical Significance of Histological Effect and Intratumor Stromal Expression of Tenascin-C in Resected Specimens After Chemoradiotherapy for Initially Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma.2018
- Author(s)
  Hayasaki A, Murata Y, Usui M, Hibi T, Ito T, Iizawa Y, Kato H, Tanemura A, Azumi Y, Kuriyama N, Kishiwada M, Mizuno S, Sakurai H, Yoshida T, Isaji S.
- Journal Title
  
  Pancreas.
  
  Volume: 47(4) Pages: 390-399
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K19881
[Presentation] 局所進行膵癌に対するgemcitabine+S1併用放射線化学療法の予後予測　EUS-FNAB検体中hENT1・DPD発現と予後との関連性2020
- Author(s)
  山田玲子, 服部愛司, 倉田一成, 重福亜紀奈, 坪井順哉, 井上宏之, 早崎碧泉, 村田泰洋, 岸和田昌之, 水野修吾, 伊佐地秀司, 竹井謙之
- Organizer
  第106回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 切除可能膵癌における術前化学放射線治療の治療成績　biological borderline膵癌に対する有効性の検討2020
- Author(s)
  村田泰洋, 早崎碧泉, 飯澤裕介, 藤井武宏, 加藤宏之, 種村彰洋, 栗山直久, 岸和田昌之, 水野修吾, 櫻井洋至, 伊佐地秀司
- Organizer
  第120回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 進行膵癌に対するConversion surgery　局所進行膵癌に対する化学放射線先行療法後の治療成績-診断時因子に注目して2020
- Author(s)
  岸和田昌之, 早崎碧泉, 尭天一亨, 藤井武宏, 飯澤祐介, 村田泰洋, 種村彰洋, 栗山直久, 櫻井洋至, 水野修吾
- Organizer
  第75回日本消化器外科学会総会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 長期成績からみた膵癌に対する集学的治療の評価　局所進行切除不能膵癌に対する化学放射線先行療法後の治療成績2020
- Author(s)
  岸和田昌之, 早崎碧泉, 藤井武宏, 飯澤祐介, 加藤宏之, 村田泰洋, 種村彰洋, 栗山直久, 水野修吾, 櫻井洋至, 伊佐地秀司
- Organizer
  第120回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 切除可能膵癌に対する術前化学放射線治療の臨床的意義　up-front surgeryとの後方視的比較検討2020
- Author(s)
  村田泰洋, 尭天一亨, 早崎碧泉, 藤井武宏, 飯澤祐介, 種村彰洋, 栗山直久, 岸和田昌之, 櫻井洋至, 水野修吾
- Organizer
  第75回日本消化器外科学会総会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 切除可能膵癌における術前化学放射線治療の臨床的意義　術後早期再発症例の検討2019
- Author(s)
  村田泰洋, 早崎碧泉, 飯澤裕介, 藤井武宏, 加藤宏之, 種村彰洋, 栗山直久, 安積良紀, 岸和田昌之, 水野修吾, 臼井正信, 櫻井洋至, 伊佐地秀司
- Organizer
  第119回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行切除不能膵癌に対するConversion surgeryの適応決定における術前癌胎児性抗原(CEA)の重要性　術直前CEA値と切除後予後に着目した臨床的研究2019
- Author(s)
  加藤宏之, 岸和田昌之, 早崎碧泉, 藤井武宏, 飯澤祐介, 村田泰洋, 種村彰洋, 安積良紀, 栗山直久, 水野修吾, 臼井正信, 櫻井洋至, 伊佐地秀司
- Organizer
  第119回日本外科学会定期学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行膵癌に対する術前化学放射線療法の治療成績　動脈浸潤と組織学効果に注目して2019
- Author(s)
  岸和田昌之, 早崎碧泉, 藤井武宏, 飯澤祐介, 加藤宏之, 村田泰洋, 種村彰洋, 栗山直久, 安積良紀, 水野修吾, 臼井正信, 櫻井洋至, 伊佐地秀司
- Organizer
  第50回日本膵臓学会大会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] Treatment strategy for R and BR pancreatic cancer patients undergoing preoperative chemoradiotherapy according to anatomical, biological and conditional factors2019
- Author(s)
  Shugo Mizuno, Aoi Hayasaki, Masashi Kishiwada, Hiroyuki Kato, Takehiro Fujii, Yusuke Iizawa, Yasuhiro Murata, Akihiro Tanemura, Naohisa Kuriyama, Yoshinori Azumi, Masanobu Usui, Hiroyuki Sakurai, Shuji Isaji
- Organizer
  第31回日本肝胆膵外科学会・学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 切除可能境界膵癌に対する術前化学放射線療法の治療成績2019
- Author(s)
  村田泰洋, 早崎碧泉, 伊佐地秀司
- Organizer
  第105回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] Impact of preoperative chemoradiotherapy for unresectable locally advanced pancreatic cancer paying attention to pre- and post-CRT biological and conditional factors2019
- Author(s)
  Masashi Kishiwada, Aoi Hayasaki, Takehiro Fujii, Yusuke Iizawa, Hiroyuki Kato, Yasuhiro Murata, Akihiro Tanemura, Naohisa Kuriyama, Yoshinori Azumi, Shugo Mizuno, Masanobu Usui, Hiroyuki Sakurai, Shuuji Isaji
- Organizer
  第31回日本肝胆膵外科学会・学術集会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 放射線化学療法の抗腫瘍効果に着目した膵癌治療前予後予測におけるノモグラムの有用性2018
- Author(s)
  加藤　宏之、岸和田　昌之、早崎　碧泉、藤井　武宏、飯澤　祐介、種村　彰洋、村田　泰洋、栗山　直久、安積　良紀、水野　修吾、臼井　正信、櫻井　洋至、小椋　透、伊佐地　秀司
- Organizer
  第49回日本膵臓学会大会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 浸潤性膵管癌に対する化学放射線治療の組織学的治療効果判定の臨床的意義2018
- Author(s)
  村田　泰洋、早崎　碧泉、飯澤　祐介、藤井　武宏、加藤　宏之、種村　彰洋、栗山　直久、安積　良紀、岸和田　昌之、水野　修吾、臼井　正信、櫻井　洋至、伊佐地　秀司
- Organizer
  第49回　日本膵臓学会
- Data Source
  KAKENHI-PROJECT-15K19881
[Presentation] 局所進行膵癌に対する化学放射線療法を先行した手術治療　切除可能性分類別にみた治療成績と組織学的治療効果の意義2018
- Author(s)
  村田　泰洋、早崎　碧泉、岸和田　昌之
- Organizer
  第104回　日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-15K19881
[Presentation] 局所進行膵癌患者における化学放射線治療施行前後での炎症/免疫栄養指標と予後との関連性について2018
- Author(s)
  市川　健、水野修吾、早崎碧泉、岸和田昌之、飯澤祐介、加藤宏之、村田泰洋、種村彰洋、栗山直久、臼井正信、櫻井洋至、伊佐地秀司
- Organizer
  第118回日本外科学会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行切除不能膵癌に対するconversion surgeryの意義と切除適応の妥当性2018
- Author(s)
  村田　泰洋、早崎　碧泉、伊佐地　秀司
- Organizer
  第26回　日本消化器病関連学会週間　JDDW 2018
- Data Source
  KAKENHI-PROJECT-15K19881
[Presentation] 局所性膵癌に対する化学放射線療法施行例における炎症/免疫栄養指標と予後の関係2018
- Author(s)
  市川　健、水野　修吾、早崎　碧泉、岸和田　昌之、飯澤　祐介、加藤　宏之、村田　泰洋、種村　彰洋、栗山　直久、臼井　正信、櫻井　洋至、伊佐地　秀司
- Organizer
  第49回日本膵臓学会大会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 切除可能膵癌に対する術前化学放射線治療の臨床的有用性　傾向スコア解析を用いた手術先行との比較研究2018
- Author(s)
  村田　泰洋、早崎　碧泉、加藤　宏之、種村　彰洋、栗山　直久、岸和田　昌之、水野　修吾、臼井　正信、櫻井　洋至、伊佐地　秀司
- Organizer
  第73回　日本消化器外科学会総会
- Data Source
  KAKENHI-PROJECT-15K19881
[Presentation] 浸潤性膵管癌に対する化学放射線治療を先行した手術治療成績　術後早期再発予測因子の解析2018
- Author(s)
  村田　泰洋、早崎　碧泉、飯澤　祐介、藤井　武宏、加藤　宏之、種村　彰洋、栗山　直久、安積　良紀、岸和田　昌之、水野　修吾、臼井　正信、櫻井　洋至、伊佐地　秀司
- Organizer
  第80回　日本臨床外科学会総会
- Data Source
  KAKENHI-PROJECT-15K19881
[Presentation] 局所進行膵癌における術前放射線化学療法施行後、遠隔転移発生の危険因子解析2017
- Author(s)
  加藤　宏之、水野修吾、早崎碧泉、尭天一亨、飯澤祐介　種村彰洋、村田泰洋、安積良紀、栗山直久、岸和田昌之、臼井正信、櫻井洋至、伊佐地秀司
- Organizer
  第48回日本膵臓学会大会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行膵癌の治療前予後予測を目的としたPredictive nomogramの作成2017
- Author(s)
  加藤　宏之、岸和田昌之、水野修吾、尭天一亨、早崎碧泉、飯澤祐介、種村彰洋、村田泰洋、安積良紀、栗山直久、臼井正信、櫻井洋至、小倉透、伊佐地秀司
- Organizer
  JDDW2017
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 局所進行膵癌に対する治療前予後予測は可能か？- 放射線化学療法前予後因子の解析とpredictive nomogramの作成-2017
- Author(s)
  加藤　宏之、岸和田昌之、尭天一亨、早崎碧泉、松井俊樹、飯澤祐介、種村彰洋、村田泰洋、安積良紀、栗山直久、水野修吾、臼井正信、櫻井洋至、伊佐地秀司、小椋透
- Organizer
  第117回日本外科学会
- Data Source
  KAKENHI-PROJECT-17K09459
[Presentation] 浸潤性膵管癌に対する化学放射線治療の組織学的効果の意義 -膵癌間質内Tenascin C発現のbiomarkerとしての有用性の検証2016
- Author(s)
  村田泰洋
- Organizer
  第116回日本外科学会定期学術集会
- Place of Presentation
  大阪国際会議場(大阪府大阪市）
- Year and Date
  2016-04-16
- Data Source
  KAKENHI-PROJECT-15K19881
[Presentation] Clinical significance of conversion surgery after gemcitabine plus S-1 based chemoradiotherapy in patients with initially locally advanced unresectable pancreatic adenocarcinoma: application of intratumoral expression of Tenascin C as a surrogate marker2016
- Author(s)
  村田泰洋
- Organizer
  IAP/JPS/AOPA 2016
- Place of Presentation
  仙台国際センター（宮城県仙台市）
- Year and Date
  2016-08-06
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K19881
[Presentation] 浸潤性膵管癌に対する化学放射線治療の組織学的効果の臨床意義ー効果判定におけるTenascin C発現の有用性ー2015
- Author(s)
  村田　泰洋
- Organizer
  JDDW 2015 日本消化器外科学会
- Place of Presentation
  グランドプリンスホテル新高輪・グランドプリンスホテル高輪(東京都港区高輪）
- Year and Date
  2015-10-10
- Data Source
  KAKENHI-PROJECT-15K19881
[Presentation] IMPACT OF HISTOLOGICAL EFFECT OF CHEMORADIOTHERAPY (CRT) ON CLINICAL OUTCOME FOR PANCREATIC ADENOCARCINOMA, PAYING ATTENTION TO INTRATUMORAL EXPRESSION OF TENASCIN C AS A POTENTIAL SURROGATE MARKER2015
- Author(s)
  村田　泰洋
- Organizer
  49th Annual meeting of the pancreas club
- Place of Presentation
  Washington DC (U.S.A)
- Year and Date
  2015-05-16
- Data Source
  KAKENHI-PROJECT-15K19881

1. 水野修吾 (70335131)

# of Collaborated Projects: 2 results

# of Collaborated Products: 28 results
2. Isaji Shuji (70176121)

# of Collaborated Projects: 1 results

# of Collaborated Products: 24 results
3. 岸和田昌之 (40501961)

# of Collaborated Projects: 1 results

# of Collaborated Products: 25 results
4. 加藤宏之 (50737004)

# of Collaborated Projects: 1 results

# of Collaborated Products: 22 results
5. 藤井武宏 (00640690)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results

Murata Yasuhiro 村田 泰洋

Research Projects

Research Products

Co-Researchers

tailor-made medicine using microRNA for pancreatic cancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Establishment and therapeutic application of a new clinical staging system based on the biological features of pancreatic adenocarcinoma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Exploring the effect of chemoradiotherapy on caner microenvironment and its clinical application in patients with pancreatic adenocarcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Anterior versus posterior radical antegrade modular pancreatosplenectomy for pancreatic body and tail cancer: an inverse probability of treatment weighting with survival analysis.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic ductal adenocarcinoma treated with chemoradiotherapy - comparison of T category between the American Joint Committee on Cancer and Japan Pancreas Society.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Predictive risk factors for early recurrence in patients with localized pancreatic ductal adenocarcinoma who underwent curative-intent resection after preoperative chemoradiotherapy2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Role of Serum Carcinoma Embryonic Antigen (CEA) Level in Localized Pancreatic Adenocarcinoma2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prognostic Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes2019

Author(s)

Journal Title

Data Source

[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor.2019

Author(s)

Journal Title

Data Source

[Journal Article] The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy.2019

Author(s)

Journal Title

Data Source

[Journal Article] Comparative Study Between Gemcitabine-Based and Gemcitabine Plus S1-Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor.2019

Author(s)

Journal Title

Data Source

[Journal Article] Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients.2019

Author(s)

Murata Yasuhiro 村田泰洋

[Presentation] 局所進行膵癌に対するgemcitabine+S1併用放射線化学療法の予後予測　EUS-FNAB検体中hENT1・DPD発現と予後との関連性2020

[Presentation] 切除可能膵癌における術前化学放射線治療の治療成績　biological borderline膵癌に対する有効性の検討2020

[Presentation] 進行膵癌に対するConversion surgery　局所進行膵癌に対する化学放射線先行療法後の治療成績-診断時因子に注目して2020

[Presentation] 長期成績からみた膵癌に対する集学的治療の評価　局所進行切除不能膵癌に対する化学放射線先行療法後の治療成績2020

[Presentation] 切除可能膵癌に対する術前化学放射線治療の臨床的意義　up-front surgeryとの後方視的比較検討2020

[Presentation] 切除可能膵癌における術前化学放射線治療の臨床的意義　術後早期再発症例の検討2019

[Presentation] 局所進行切除不能膵癌に対するConversion surgeryの適応決定における術前癌胎児性抗原(CEA)の重要性　術直前CEA値と切除後予後に着目した臨床的研究2019

[Presentation] 局所進行膵癌に対する術前化学放射線療法の治療成績　動脈浸潤と組織学効果に注目して2019

[Presentation] 局所進行膵癌に対する化学放射線療法を先行した手術治療　切除可能性分類別にみた治療成績と組織学的治療効果の意義2018